Developing low cost therapies: Practical tips

Isatuximab Subgroup Data Analyses Show Opportunity for Durable Responses in Elderly, Frail, and Renally Impaired Patients With RRMM

Complex technologies for advanced diagnosis and precision medicine in oncology

Genomic testing in biliary tract cancers

Molecular profiling in prostate cancer: key challenges for clinical implementation

Genomic testing: Australian model for unlocking the potential of precision oncology for patients and health systems

Final OS analysis of ICARIA-MM: Isatuximab triplet shows continued survival benefit in R/R multiple myeloma

ESMO 2022: Lung roundup

Xevinapant plus standard of care chemoradiotherapy improved 5 year OS for unresected LA SCCHN

Tislelizumab demonstrates non-inferior OS compared to sorafenib for treating hepatocellular carcinoma

Abemaciclib plus trastuzumab fulvestrant increased OS for HR+, HER2+ advanced breast cancer

ESMO 2022: Breast and ovarian trial analysis